In:
British Journal of Pharmacology, Wiley, Vol. 171, No. 21 ( 2014-11), p. 4866-4878
Abstract:
Sepsis is a clinical condition characterized by overwhelming systemic inflammation with high mortality rate and high prevalence, but effective treatment is still lacking. Toll‐like receptor 3 ( TLR3 ) is an endogenous sensor, thought to regulate the amplification of immune response during sepsis. Modulators of TLR3 have an advantage in the treatment of sepsis. Here, we aimed to explore the mechanism of a monosubstituted 1,2‐benzenediamine derivative FC ‐99 {N 1 ‐[(4‐methoxy)methyl]‐4‐methyl‐1,2‐benzenediamine}on modulating TLR3 expression and its therapeutic potential on mouse model of sepsis. Experimental Approach Cells were pretreated with FC ‐99 followed by poly( I:C ) or IFN ‐α stimulation; TLR3 and other indicators were assayed. Female C57BL /6 mice were subjected to sham or caecal ligation puncture ( CLP ) surgery after i.p. injection of vehicle or FC ‐99; serum and tissues were collected for further experiments. Key Results FC ‐99 suppressed inflammatory response induced by poly( I:C ) with no effect on cell viability or uptake of poly( I:C ). FC ‐99 also inhibited TLR3 expression induced by not only poly( I:C ) but also by exogenous IFN ‐α. This inhibition of FC ‐99 was related to the poly( I:C )‐evoked IRF3/IFN‐α/JAK/STAT1 signalling pathway. In CLP ‐induced model of sepsis, FC ‐99 administration decreased mice mortality and serum levels of inflammatory factors, attenuated multiple organ dysfunction and enhanced bacterial clearance. Accordingly, systemic and local expression of TLR3 was reduced by FC ‐99 in vivo . Conclusion and Implications FC ‐99 reversed TLR3 expression and ameliorate CLP ‐induced sepsis in mice. Thus, FC ‐99 will be a potential therapeutic candidate for sepsis.
Type of Medium:
Online Resource
ISSN:
0007-1188
,
1476-5381
DOI:
10.1111/bph.2014.171.issue-21
Language:
English
Publisher:
Wiley
Publication Date:
2014
detail.hit.zdb_id:
2029728-2
SSG:
15,3
